510(k) K060628

Device
DIMENSION TBI FLEX AND DBI FLEX REAGENT CARTRIDGES AND TBI/DBI CALIBRATOR
Applicant
DADE BEHRING, INC.
510(k) number
K060628
Product code
CIG  
Decision
Substantially Equivalent (SESE)
Decision date
2006-04-06
Date received
2006-03-09
Regulation
862.1110
Classification name
Diazo Colorimetry, Bilirubin
Medical specialty
Clinical Chemistry
Review panel
Clinical Chemistry
Device class
2
Clearance type
Special
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
GEORGE M PLUMMER
Address
Glasgow Business Community Bldg. 500, Ms 514 P.O.Box 6101 Newark DE US 19714 19714

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code CIG  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K251998Atellica CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc.2026-02-27
K223078Atellica® CH Diazo Direct Bilirubin (D_DBil)Siemens Healthcare Diagnostics, Inc.2023-06-12
K222104Atellica® CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc.2023-03-20
K223324Total Bilirubin2Abbott Ireland Diagnostics Division2022-12-29
K190807VITROS XT Chemistry Products TBIL-ALKP SlidesOrtho-Clinical Diagnostics, Inc.2019-04-26
K171401ELITech Clinical Systems BILIRUBIN TOTAL 4+1, ELITech Clinical Systems BILIRUBIN DIRECT 4+1Elitechgroup2017-07-11
K150510Total BilirubinAbbott Laboratories2015-04-02
K131544COBAS C BILIRUBIN TOTAL GEN.3Roche Diagnostics2013-07-17
K131217S TEST REAGENT CARTRIDGE TOTAL BILIRUBINHitachi Chemical Diagnostics, Inc.2013-06-07
K123802EASYRA TBIL REAGENT, EASYRA DBII REAGENT, EASYRA CK REAGENTMedica Corp.2013-03-01
K123965COBAS INTEGRA BILIRUBIN DIRECT GEN.2Roche Diagnostics2013-02-28
K121985ARCHITECT TOTAL BILIRUBINAbbott Laboratories2013-02-01
K110780ELITECH CLINICAL SYSTEMS BILIRUBIN TOTAL 4+1, ELITECH CLINICAL SYSTEMS ELICAL 2, ELITECH CLINICAL SYSTMES ELITROL I & IIElitechgroup2011-10-07
K111143POLY-CHEM 90 TOTAL BILIRUBINPolymedco, Inc.2011-09-01
K093623GEM PREMIER 4000 WITH IQM (ADDITION OF TOTAL BILIRUBIN PARAMETER), GEM CVP 2 (ADDITION OF TOTAL BILIRUBIM ASSIGNMENT TOInstrumentation Laboratory CO2010-06-18

Legacy Summary#

summary

FDA Review#

Decision Summary